NEMA HEALTH
LIVE

Serial Number

79438311

Owner

Nema Health S.L.

Filing Date

Oct 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NEMA HEALTH Trademark

Serial Number: 79438311

NEMA HEALTH is a trademark filed by Nema Health S.L. on October 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Nema Health S.L.

Parc de Gardeny Edifici CeDiCo, planta Baixa

Entity Type: 99

Trademark Details

Filing Date

October 23, 2025

Registration Date

Not Registered

Goods & Services

Anticancer drugs; anticancer preparations; pharmaceutical products; chemico-pharmaceutical products; regenerative tissue [pharmaceutical preparations]; bacteriological preparations for pharmaceutical use; synthetic peptides for pharmaceutical use; chemical preparations for pharmaceutical use; chemical products for pharmaceutical purposes; pharmaceutical preparations containing stem cells; pharmaceutical products for cancer treatment; transdermal patches for administering pharmaceutical products; filled syringes for medical purposes containing pharmaceuticals; medical products; cells for medical use; diagnostic preparations for medical use in medical laboratories; immunoassay reagents for medical use; reagents with biomarkers for medical diagnostics; diagnostic preparations for medical use; diagnostic substances for medical use; diagnostic preparations and materials for medical and veterinary use; hygienic preparations for medical use.

Scientific research; biotechnological research; biochemical research; biological research, clinical research and medical research; genetic research; chemical research; research services; pharmaceutical research and development; scientific research and development; consultancy regarding pharmaceutical research; scientific analysis and research services; research in the field of nanobiotechnology; medical and pharmacological research services; research and development of pharmaceutical preparations for treating malignant tumors; consultancy relating to pharmaceutical research and development; research in the field of pharmacogenetics; information on scientific research in the field of biochemistry and biotechnology; research and development services in immunology; research in the field of immunodeficiency; scientific and technological design; scientific design services; scientific and technological services; scientific testing services; scientific research for medical purposes; consulting in the field of scientific research; technological and scientific services; scientific laboratory services; research in the field of genetic diseases; medical research in the field of rare diseases; research in the field of gene therapies; advisory services relating to gene therapy research.

Filing History

REFUSAL PROCESSED BY IB
Jun 18, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 24, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 24, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 13, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 12, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2025 REPR